Goldentree Asset Management Lp — Insider Trades & Holdings | InsiderBid

Goldentree Asset Management Lp

Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: +$368.2M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
—	Keenova Therapeutics plc	$102.1M	$0	+$102.1M	9M	Nov 10
QVCG	QVC Group, Inc.	$71.3M	$0	+$71.3M	12.7M	Oct 9
—	GoldenTree Opportunistic Credit Fund	$194.9M	$0	+$194.9M	23.6M	Jun 9

—

Keenova Therapeutics plc

+$102.1M

Bought

$102.1M

Sold

$0

Held

9M

QVC Group, Inc.

+$71.3M

Bought

$71.3M

Sold

$0

Held

12.7M

—

GoldenTree Opportunistic…

+$194.9M

Bought

$194.9M

Sold

$0

Held

23.6M

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

3 of 30 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 130 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Jul 31, 2025	Feb 11	—Keenova Therapeutics plc	130days · about 6 months	—	Filing ↗
Dec 15, 2025	Apr 22	—GoldenTree Opportunistic Credit…	86days · about 4 months	$37.5M	Filing ↗
Sep 24	Oct 6	—Keenova Therapeutics plc

Trade history

The 52 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Nov 10	—	Keenova Therapeutics plc	PBUY	120,652	$91.00	$11M	+1.4%	Open the original filing on SEC.gov
Nov 9	—	Keenova Therapeutics plc	PBUY	30,000	$89.25	$2.7M	+0.3%	Open the original filing on SEC.gov
Nov 6

—PBUY$11M

Keenova Therapeutics plcNov 10

120,652 sh @ $91.00 · +1.4% own

—PBUY$2.7M

Keenova Therapeutics plcNov 9

30,000 sh @ $89.25 · +0.3% own

—PBUY$13.4M

Keenova Therapeutics plcNov 6

150,000 sh @ $89.25 · +1.7% own

—PBUY$13M

Keenova Therapeutics plcNov 5

145,716 sh @ $89.25 · +1.7% own

—PBUY$12.3M

Keenova Therapeutics plcOct 14

137,000 sh @ $90.00 · +1.6% own

QVCGPBUY$16.7M

QVC Group, Inc.Oct 9

1.4M sh @ $12.35 · +11.9% own

QVCGPBUY$3.5M

QVC Group, Inc.Oct 2

250,000 sh @ $13.85 · +2.3% own

QVCGPBUY$27.6K

QVC Group, Inc.Oct 1

2,024 sh @ $13.63 · +<0.1% own

QVCGPBUY$11.5K

QVC Group, Inc.Oct 1

848 sh @ $13.61 · +<0.1% own

QVCGPBUY$39.6K

QVC Group, Inc.Sep 30

2,907 sh @ $13.61 · +<0.1% own

—PBUY$42.1M

Keenova Therapeutics plcSep 24

463,000 sh @ $91.00 · +5.8% own

QVCGPBUY$1.1M

QVC Group, Inc.Sep 24

80,000 sh @ $14.35 · +0.7% own

QVCGPBUY$26M

QVC Group, Inc.Sep 8

1.6M sh @ $16.25 · +17.0% own

QVCGPBUY$11.8M

QVC Group, Inc.Sep 3

720,000 sh @ $16.45 · +8.3% own

QVCGPBUY$14.6K

QVC Group, Inc.Aug 28

915 sh @ $15.98 · +<0.1% own

QVCGPBUY$83K

QVC Group, Inc.Aug 27

5,216 sh @ $15.91 · +<0.1% own

QVCGPBUY$275.4K

QVC Group, Inc.Aug 27

17,478 sh @ $15.76 · +0.2% own

QVCGPBUY$1.3K

QVC Group, Inc.Aug 26

87 sh @ $15.25 · 0.0% own

QVCGPBUY$5K

QVC Group, Inc.Aug 26

325 sh @ $15.30 · 0.0% own

QVCGPBUY$31.1K

QVC Group, Inc.Aug 25

2,039 sh @ $15.23 · +<0.1% own

QVCGPBUY$41K

QVC Group, Inc.Aug 24

2,690 sh @ $15.23 · +<0.1% own

QVCGPBUY$3K

QVC Group, Inc.Aug 21

200 sh @ $15.24 · 0.0% own

QVCGPBUY$4.6K

QVC Group, Inc.Aug 20

300 sh @ $15.25 · 0.0% own

QVCGPBUY$212.6K

QVC Group, Inc.Aug 19

13,980 sh @ $15.21 · +0.2% own

QVCGPBUY$6.1K

QVC Group, Inc.Aug 18

400 sh @ $15.25 · 0.0% own

QVCGPBUY$610.8K

QVC Group, Inc.Aug 17

40,253 sh @ $15.17 · +0.5% own

QVCGPBUY$65.4K

QVC Group, Inc.Aug 17

4,289 sh @ $15.24 · +<0.1% own

QVCGPBUY$334K

QVC Group, Inc.Aug 14

22,017 sh @ $15.17 · +0.3% own

QVCGPBUY$354.8K

QVC Group, Inc.Aug 13

23,321 sh @ $15.22 · +0.3% own

QVCGPBUY$4.7K

QVC Group, Inc.Aug 11

308 sh @ $15.20 · 0.0% own

QVCGPBUY$7.6K

QVC Group, Inc.Aug 10

500 sh @ $15.22 · +<0.1% own

QVCGPBUY$3.9M

QVC Group, Inc.Aug 10

250,000 sh @ $15.75 · +3.0% own

QVCGPBUY$2.3M

QVC Group, Inc.Aug 7

150,000 sh @ $15.00 · +1.8% own

QVCGPBUY$3.8M

QVC Group, Inc.Aug 7

250,000 sh @ $15.15 · +3.2% own

—PBUY$4.8M

GoldenTree Opportunistic…Jun 9

465,230.17 sh @ $10.21 · +2.0% own

—PBUY$12.8M

GoldenTree Opportunistic…May 26

1.3M sh @ $10.16 · +5.8% own

—PBUY$20M

GoldenTree Opportunistic…Apr 24

2M sh @ $10.22 · +9.9% own

—PBUY$37.5M

GoldenTree Opportunistic…Apr 21

3.7M sh @ $10.24 · +22.7% own

—PBUY$10M

GoldenTree Opportunistic…Feb 13

971,817.3 sh @ $10.29 · +6.5% own

—JOTHER—

GoldenTree Opportunistic…Dec 15, 2025

146,056.48 sh · +0.9% own

—PBUY$20M

GoldenTree Opportunistic…Nov 28, 2025

1.9M sh @ $10.26 · +15.1% own

—PBUY$4.9M

GoldenTree Opportunistic…Sep 12, 2025

482,283.47 sh @ $10.16 · +32.0% own

—PBUY$25M

GoldenTree Opportunistic…Sep 12, 2025

2.5M sh @ $10.16 · +23.5% own

—PBUY$5M

GoldenTree Opportunistic…Aug 28, 2025

494,559.84 sh @ $10.11 · +49.0% own

—PBUY$25M

GoldenTree Opportunistic…Aug 28, 2025

2.5M sh @ $10.11 · +31.0% own

—PBUY$15M

GoldenTree Opportunistic…Aug 11, 2025

1.5M sh @ $10.05 · +23.0% own

—PBUY$15M

GoldenTree Opportunistic…Aug 7, 2025

1.5M sh @ $10.04 · +29.9% own

—PBUY$619.8K

Keenova Therapeutics plcAug 6, 2025

6,700 sh @ $92.50 · +<0.1% own

—PBUY$2.6M

Keenova Therapeutics plcAug 4, 2025

30,000 sh @ $87.25 · +0.4% own

—PBUY$4.3M

Keenova Therapeutics plcAug 1, 2025

50,000 sh @ $86.50 · +0.6% own

—JOTHER—

Keenova Therapeutics plcJul 31, 2025

4.5M sh · +136.7% own

—JOTHER—

Keenova Therapeutics plcJul 31, 2025

33,651 sh · +0.4% own